{
    "data": [
        {
            "id": "DJN_DN20250205005391:0",
            "title": "Johnson Controls Names Weidemanis CEO, Logs 1Q Income Growth",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><span><p class=\"\">By Rob Curran</p><p class=\"\">Johnson Controls named Danaher executive Joakim Weidemanis as chief executive to succeed George Oliver, who last year divulged plans to step down following pressure from activist investment firm Elliott Investments.</p><p class=\"\">Separately, the maker of heating, ventilation and air-conditioning machinery posted fiscal first-quarter earnings growth and boosted its earnings projection for the year ending in September.</p><p class=\"\">Weidemanis is slated to start as CEO on March 12. Oliver will remain as nonexecutive chairman until July 31, at which point he will be succeeded in that role by Mark Vergnano, who has sat on the board since 2016. Oliver will then serve as an adviser, supporting the leadership transition until the end of 2025.</p><p class=\"\">Weidemanis had a 13-year career as an executive at industrial conglomerate Danaher, most recently as executive vice president, diagnostics and China, and he previously worked at Swiss industrial firm ABB.</p><p class=\"\">Johnson posted earnings of $419 million, or 63 cents a share, for the quarter ended in December, up from $374 million, or 55 cents a share, a year earlier.</p><p class=\"\">On an adjusted basis, the Ireland-based company logged earnings of 64 cents a share, compared with the mean analyst estimate of 59 cents a share, per FactSet.</p><p class=\"\">Sales rose 4% to $5.43 billion, surpassing the mean analyst estimate of $5.29 billion.</p><p class=\"\">For the fiscal second quarter, Johnson targeted adjusted earnings between 77 cents and 79 cents a share.</p><p class=\"\">For the fiscal year, the company boosted its forecast for adjusted earnings to a range between $3.50 and $3.60 a share from a previous target of $3.40 to $3.50 a share.</p><p class=\"\">Johnson started a chief-executive search in July, when Oliver disclosed plans to step down in response to an activist-investor campaign from Elliott. Oliver noted the company's tightening of its focus during his tenure.</p><p class=\"\">Write to Rob Curran at rob.curran@dowjones.com</p></span></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20250205005391:0/",
            "pub_date": "2025-02-05 20:39:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20250205005396:0",
            "title": "Intuitive Machines Initiated at Underperform by B of A Securities",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><span><p class=\"\"><strong class=\"root-Tkn6WL2y\">(12:39 GMT) </strong>Intuitive Machines Price Target Announced at $16.00/Share by B of A Securities</p></span></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20250205005396:0/",
            "pub_date": "2025-02-05 20:39:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20250205005383:0",
            "title": "Dayforce 4Q Profit Declines Despite Revenue Increase, Outlook Below Expectations",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><span><p class=\"\">By Denny Jacob</p><p class=\"\">Dayforce posted lower profit in fourth quarter despite higher revenue, while its outlook for the current quarter and year came in below what Wall Street expected.</p><p class=\"\">The company, whose offerings include providing human resources, payroll and benefits, recorded net income of $10.8 million, or 7 cents a share, compared to $45.6 million, or 29 cents a share, a year earlier.</p><p class=\"\">Stripping out certain one-time items, earnings came in at 60 cents a share. Analysts polled by FactSet expected 58 cents a share.</p><p class=\"\">Revenue rose to $465.2 million from $399.7 million. Analysts polled by FactSet expected $482.3 million.</p><p class=\"\">\"The fourth quarter of 2024 was the strongest sales quarter in our history — helping us close out a successful year with robust growth across both new business and add-on sales,\" said Chief Operating Officer Stephen Holdridge.</p><p class=\"\">Dayforce guided for revenue, excluding float, between $421 million and $427 million in the first quarter. Analysts polled by FactSet expected $482.3 million.</p><p class=\"\">For 2025, Dayforce forecast revenue growth excluding float to come in between $1.75 billion and $1.76 billion. Analysts polled by FactSet expected $1.96 billion.</p><p class=\"\">Write to Denny Jacob at denny.jacob@wsj.com</p></span></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20250205005383:0/",
            "pub_date": "2025-02-05 20:39:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20250205005394:0",
            "title": "8X8 Is Maintained at Equal-Weight by Barclays",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20250205005394:0/",
            "pub_date": "2025-02-05 20:39:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "urn:newsml:mtnewswires.com:20250205:A3309817:0",
            "title": "GUIDANCE: (LUCK) Lucky Strike Entertainment Expects Fiscal 2025 Revenue Range $1.23 Billion - $1.28 Billion, vs. FactSet Est of $1.25 Billion",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"></div>",
            "link": "https://www.tradingview.com/news/mtnewswires.com:20250205:A3309817:0/",
            "pub_date": "2025-02-05 20:39:01",
            "source": "MT Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2025:newsml_L4N3OW19H:0",
            "title": "Evercore rises as Q4 results sail past Wall Street views",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><span><p class=\"\">** Investment bank Evercore's  shares rise ~2% to $288.50 premarket </p><p class=\"\">** Co reports Q4 adjusted profit of $3.41 per share, comfortably surpassing Wall Street estimates of $2.85, according to data compiled by LSEG </p><p class=\"\">** Dealmaking has seen an industry-wide resurgence with companies once again pursuing initial public offerings, mergers and acquisitions as well as equity and debt sales </p><p class=\"\">** This follows nearly three years of dull activity that hit investment banks across the sector, due to elevated rates, capital markets volatility and anti-trust enforcement actions </p><p class=\"\">** EVR's revenue was $980.5 mln in the quarter, beating analyst expectations of $885.1 mln </p><p class=\"\">** Market environment has also been favorable for banks amid anticipation that President Donald Trump will usher in a  business-friendly and deregulatory agenda </p><p class=\"\">** EVR's advisory fees business logs a 29% jump in Q4, while underwriting fees increases 38% </p><p class=\"\">** Stock up 2% YTD, as of previous close; It surged ~62% in 2024 </p></span></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2025:newsml_L4N3OW19H:0-evercore-rises-as-q4-results-sail-past-wall-street-views/",
            "pub_date": "2025-02-05 20:39:10",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "urn:newsml:mtnewswires.com:20250205:A3309786:0",
            "title": "Emerson Electric Fiscal Q1 Adjusted Earnings, Net Sales Rise",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><span><p class=\"\">Emerson Electric  reported fiscal Q1 adjusted earnings Wednesday of $1.38 per diluted share, compared with $1.22 a year earlier. </p><p class=\"\">Analysts polled by FactSet expected $1.28. </p><p class=\"\">Net sales for the quarter ended Dec. 31 were $4.18 billion, up from $4.12 billion a year earlier. </p><p class=\"\">Analysts surveyed by FactSet expected $4.22 billion. </p><p class=\"\">Emerson said it expects fiscal Q2 adjusted EPS in the range of $1.38 to $1.42. Analysts polled by FactSet expect $1.45. Net sales for the quarter are expected to decrease or increase by 0.5%. Analysts surveyed by FactSet expect $4.50 billion. </p><p class=\"\">The company continues to expect fiscal 2025 adjusted EPS in the range of $5.85 to $6.05. Analysts polled by FactSet expect $5.93. Net sales for the current fiscal year are now projected to grow 1.5% to 3.5%, compared with 3.5% to 5.5% anticipated previously. Analysts surveyed by FactSet predict $18.17 billion. </p><p class=\"\">Additionally, the company said it has maintained its quarterly dividend at $0.5275 per share, payable March 10 to shareholders of record as of Feb. 14.</p></span></div>",
            "link": "https://www.tradingview.com/news/mtnewswires.com:20250205:A3309786:0/",
            "pub_date": "2025-02-05 20:39:11",
            "source": "MT Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "urn:newsml:mtnewswires.com:20250205:A3309813:0",
            "title": "New York Times' Q4 Adjusted Earnings, Revenue Rise",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><span><p class=\"\">The New York Times Co.  reported Q4 adjusted earnings Wednesday of $0.80 per diluted share, up from $0.70 a year earlier. </p><p class=\"\">Analysts surveyed by FactSet expected $0.75</p><p class=\"\">Revenue for the quarter ended Dec. 31 was $726.6 million, compared with $676.2 million a year earlier. </p><p class=\"\">Analysts surveyed by FactSet expected $726.8 million.</p></span></div>",
            "link": "https://www.tradingview.com/news/mtnewswires.com:20250205:A3309813:0/",
            "pub_date": "2025-02-05 20:39:17",
            "source": "MT Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2025:newsml_FWN3OW0DQ:0",
            "title": "Aurora Cannabis Announces Fiscal 2025 Third Quarter Results",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><span><p class=\"\">Aurora Cannabis Inc :</p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\">AURORA CANNABIS INC: QTRLY TOTAL NET REVENUE OF $88.2 MILLION</p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\">AURORA CANNABIS INC - Q3 TOTAL NET REVENUE $88.2 MILLION, UP 37% YOY</p></li></ul></span></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2025:newsml_FWN3OW0DQ:0-aurora-cannabis-announces-fiscal-2025-third-quarter-results/",
            "pub_date": "2025-02-05 20:39:33",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "urn:newsml:mtnewswires.com:20250205:A3309822:0",
            "title": "RBC Trims Price Target on Amgen to $320 From $324, Keeps Outperform Rating",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><span><p class=\"\">Amgen  has an average rating of overweight and mean price target of $314.54, according to analysts polled by FactSet.</p></span></div>",
            "link": "https://www.tradingview.com/news/mtnewswires.com:20250205:A3309822:0/",
            "pub_date": "2025-02-05 20:39:44",
            "source": "MT Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2025-02-05:newsml_SEEWQ13ma:0",
            "title": "Bulgaria sees EU's second-highest y/y rise in industrial PPI in Dec",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><span><p class=\"\">SOFIA (Bulgaria), February 5 (SeeNews) - Bulgaria registered the EU's second-largest annual increase in the industrial producer price index (PPI) in December, at 6.6%, Eurostat said on Wednesday.</p><p class=\"\">At the same time, Bulgaria marked the EU's highest month-on-month growth in industrial PPI, at 5.1%, followed by Croatia with 2.4%, the bloc's statistical office said in a data release.</p><p class=\"\">Romania's industrial producer prices, on the other hand, posted the second-sharpest monthly decline in the bloc, at 1.3%, while industrial PPI in the EU overall climbed 0.4% in December compared to the previous month.</p><p class=\"\">On an annual comparison basis, Romania's industrial PPI fell the most among EU member states in Southeast Europe (SEE), by 2.3%, against a bloc average rise of 0.1%.</p><p class=\"\">Below are the percentage changes in the PPI of EU member states in SEE in December:</p><p class=\"\">EU member state...Dec y/y...Dec m/m</p><div class=\"tableWrapper-pIO_GYwT\"><table class=\"table-VG8_37yK\" data-no-swipe=\"true\"><tr><td>Bulgaria</td><td>6.6</td><td>5.1</td></tr><tr><td>Croatia</td><td>-2.2</td><td>2.4</td></tr><tr><td>Greece</td><td>-0.5</td><td>0.4</td></tr><tr><td>Romania</td><td>-2.3</td><td>-1.3</td></tr><tr><td>Slovenia</td><td>-0.2</td><td>0.3</td></tr><tr><td>EU average</td><td>0.1</td><td>0.4</td></tr></table></div><p class=\"\">Source: Eurostat</p> </span></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2025-02-05:newsml_SEEWQ13ma:0-bulgaria-sees-eu-s-second-highest-y-y-rise-in-industrial-ppi-in-dec/",
            "pub_date": "2025-02-05 20:40:07",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2025:newsml_TUA3RTTLP:0",
            "title": "Matador Acquires 3.46 Bitcoin for CAD$500,000, Bringing Its Total Bitcoin (and Bitcoin Equivalent) Holdings to 68.14",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><span><p class=\"\">Matador Technologies Inc :</p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\">MATADOR ACQUIRES 3.46 BITCOIN FOR CAD$500,000, BRINGING ITS TOTAL BITCOIN (AND BITCOIN EQUIVALENT) HOLDINGS TO 68.14</p></li></ul></span></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2025:newsml_TUA3RTTLP:0-matador-acquires-3-46-bitcoin-for-cad-500-000-bringing-its-total-bitcoin-and-bitcoin-equivalent-holdings-to-68-14/",
            "pub_date": "2025-02-05 20:40:14",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "urn:newsml:mtnewswires.com:20250205:G2464027:0",
            "title": "Barclays Says Novo Nordisk's Q4 2024 Results 'Good Enough' to Get Back On Track",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><span><p class=\"\">Barclays on Wednesday said Novo Nordisk's (NOVO-B.CO) latest earnings results were \"good enough\" to get the company back on track, as it delivered a better-than-expected financial performance in the fourth quarter of 2024. </p><p class=\"\">With Novo Nordisk reporting 85.7 billion Danish kroner in sales and an operating profit of 37 billion kroner for the quarter, respectively 8% and 14% above Barclays estimates, analysts are now more optimistic about the Danish pharmaceutical company's prospects for 2025. </p><p class=\"\">\"The company did see a ~DKK 5bn GTN tailwind in the Q (70% of which was on insulin); after adjusting for this sales growth would have been ~23%...but with Ozempic in-line with consensus (we'd been below) and Wegovy an LSD% miss, we think this is a good enough print to get shares moving back in the right direction as this had been the print feared the most across our coverage,\" analysts said. </p><p class=\"\">Novo Nordisk's guidance of 16% to 24% sales growth for full-year 2025 and 19% to 27% operating profit growth is also in line with consensus. </p><p class=\"\">Barclays rates the stock at overweight, with a price target of 900 kroner.</p></span></div>",
            "link": "https://www.tradingview.com/news/mtnewswires.com:20250205:G2464027:0/",
            "pub_date": "2025-02-05 20:40:15",
            "source": "MT Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "urn:newsml:mtnewswires.com:20250205:A3309808:0",
            "title": "Earnings Flash (FSV) FIRSTSERVICE CORPORATION Posts Q4 Adjusted EPS $1.34, vs. FactSet Est of $1.38",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"></div>",
            "link": "https://www.tradingview.com/news/mtnewswires.com:20250205:A3309808:0/",
            "pub_date": "2025-02-05 20:33:27",
            "source": "MT Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "urn:newsml:mtnewswires.com:20250205:A3309748:0",
            "title": "Ascot Resources Reports Delay in Mill Restart at Premier Gold Project in British Columbia",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><span><p class=\"\">Ascot Resources  reported Wednesday a delay in the restart of mill operations at the Premier gold project in British Columbia. </p><p class=\"\">The company cited limited availability of trained labor, which caused underground development to commence later than expected. </p><p class=\"\">Ascot said it now projects ore throughput to commence in July. It is finalizing revised schedule and budget to reflect the updated timeline. </p><p class=\"\">\"Following my initial review, the mill and deposit are both expected to perform in line with prior guidance,\" said Jim Currie, Ascot's president and CEO. \"However, the delay in development will result in a working capital shortfall.\"</p><p class=\"\">\"As such, we are actively engaged in discussions with our major shareholders, debt providers, and bankers to address the funding gap,\" Currie added.</p></span></div>",
            "link": "https://www.tradingview.com/news/mtnewswires.com:20250205:A3309748:0/",
            "pub_date": "2025-02-05 20:33:31",
            "source": "MT Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "urn:newsml:mtnewswires.com:20250205:G2463990:0",
            "title": "Mediobanca Downgrades Swatch Group to Underperform, Cuts PT",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><span><p class=\"\">Mediobanca on Wednesday downgraded Swiss watches and jewelry manufacturer The Swatch Group's  rating to underperform from neutral and decreased its price target to 150.00 francs from 200.00 francs.</p></span></div>",
            "link": "https://www.tradingview.com/news/mtnewswires.com:20250205:G2463990:0/",
            "pub_date": "2025-02-05 20:33:46",
            "source": "MT Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "urn:newsml:mtnewswires.com:20250205:G2464036:0",
            "title": "Acarix Partners with Geo-Med To Improve CADScor System Access for US veterans",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><span><p class=\"\">Acarix  entered into a strategic partnership with Geo-Med, a service-disabled veteran-owned small business, to enhance access to its CADScor System for US veterans. </p><p class=\"\">The partnership looks to streamline the adoption of technology systems within veteran healthcare networks for better distribution, ensuring diagnostics for early detection of coronary artery disease, the Swedish medical device company said Wednesday.</p></span></div>",
            "link": "https://www.tradingview.com/news/mtnewswires.com:20250205:G2464036:0/",
            "pub_date": "2025-02-05 20:33:51",
            "source": "MT Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2025:newsml_FWN3OW19E:0",
            "title": "Griffon Corporation Announces First Quarter Results",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><span><p class=\"\">Griffon Corp :</p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\">: QTRLY EPS $1.49</p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\">Q1 EARNINGS PER SHARE VIEW $1.19 — LSEG IBES DATA</p></li></ul></span></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2025:newsml_FWN3OW19E:0-griffon-corporation-announces-first-quarter-results/",
            "pub_date": "2025-02-05 20:33:57",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2025:newsml_L4N3OW19C:0",
            "title": "New York Times forecasts first-quarter subscription revenue below estimates",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><span><p class=\"\">The New York Times  forecast first-quarter subscription revenue growth below Wall Street estimates on Wednesday, signaling growing competition to attract new subscribers.</p><p class=\"\">Major news organizations including CNN and The Verge recently started offering paid subscriptions for online content amid an intensely competitive and crowded market.</p><p class=\"\">The New York Times expects subscription revenue growth of 7% to 10%, compared with analysts' average estimate of 9.9% in the first quarter, according to data compiled by Visible Alpha.</p><p class=\"\">It forecast digital-only quarterly subscription revenues of 14% to 17%, above expectations of 13.6%.</p><p class=\"\">Total revenue in the fourth quarter ended Dec. 31 was $726.6 million, in line with the average estimates compiled by LSEG.</p></span></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2025:newsml_L4N3OW19C:0-new-york-times-forecasts-first-quarter-subscription-revenue-below-estimates/",
            "pub_date": "2025-02-05 20:34:09",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "urn:newsml:mtnewswires.com:20250205:A3309804:0",
            "title": "Deutsche Bank Adjusts Merck Price Target to $128 From $132, Maintains Buy Rating",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><span><p class=\"\">Merck  has an average rating of overweight and mean price target of $117.47, according to analysts polled by FactSet.</p></span></div>",
            "link": "https://www.tradingview.com/news/mtnewswires.com:20250205:A3309804:0/",
            "pub_date": "2025-02-05 20:34:50",
            "source": "MT Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "urn:newsml:mtnewswires.com:20250205:G2464039:0",
            "title": "South Korea's Inflation Accelerates for the Fourth Straight Month, Up 2.2% in January",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"></div>",
            "link": "https://www.tradingview.com/news/mtnewswires.com:20250205:G2464039:0/",
            "pub_date": "2025-02-05 20:34:57",
            "source": "MT Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "urn:newsml:mtnewswires.com:20250205:A3309809:0",
            "title": "Deutsche Bank Adjusts Advanced Micro Devices Price Target to $120 From $150, Maintains Hold Rating",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><span><p class=\"\">Advanced Micro Devices  has an average rating of overweight and mean price target of $156.98, according to analysts polled by FactSet.</p></span></div>",
            "link": "https://www.tradingview.com/news/mtnewswires.com:20250205:A3309809:0/",
            "pub_date": "2025-02-05 20:35:01",
            "source": "MT Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "urn:newsml:mtnewswires.com:20250205:G2464038:0",
            "title": "CITIC Securities' Associate Logs 2.16 Billion Yuan in Net Profit in 2024",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><span><p class=\"\">CITIC Securities'  controlled subsidiary China Asset Management realized a net profit of 2.16 billion yuan in 2024, a Wednesday Hong Kong bourse filing said. </p><p class=\"\">China Asset Management's operating revenue for the year was seen at 8.03 billion yuan, the filing said.</p></span></div>",
            "link": "https://www.tradingview.com/news/mtnewswires.com:20250205:G2464038:0/",
            "pub_date": "2025-02-05 20:35:06",
            "source": "MT Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "urn:newsml:mtnewswires.com:20250205:A3309816:0",
            "title": "RBC Lifts Price Target on AECOM to $125 From $124, Keeps Outperform Rating",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><span><p class=\"\">AECOM  has an average rating of overweight and mean price target of $123.80, according to analysts polled by FactSet.</p></span></div>",
            "link": "https://www.tradingview.com/news/mtnewswires.com:20250205:A3309816:0/",
            "pub_date": "2025-02-05 20:35:27",
            "source": "MT Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2025:newsml_FWN3OW0Y1:0",
            "title": "Vishay Intertechnology Reports Fiscal Fourth Quarter and Full Year 2024 Results",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><span><p class=\"\">Vishay Intertechnology Inc :</p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\">VISHAY INTERTECHNOLOGY INC: QTRLY  ADJUSTED EPS OF $0.00</p></li></ul></span></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2025:newsml_FWN3OW0Y1:0-vishay-intertechnology-reports-fiscal-fourth-quarter-and-full-year-2024-results/",
            "pub_date": "2025-02-05 20:35:28",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2025:newsml_TUA1NZG8H:0",
            "title": "Core Scientific Announces January 2025 Production and Operations Updates",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><span><p class=\"\">Core Scientific Inc :</p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\">CORE SCIENTIFIC ANNOUNCES JANUARY 2025 PRODUCTION AND OPERATIONS UPDATES</p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\">CORE SCIENTIFIC INC: EARNED 256 SELF-MINING BITCOIN IN JANUARY</p></li></ul></span></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2025:newsml_TUA1NZG8H:0-core-scientific-announces-january-2025-production-and-operations-updates/",
            "pub_date": "2025-02-05 20:35:46",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20250205005250_20250205005250:0",
            "title": "Lucky Strike Ent 2Q Rev $300.1M >LUCK",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20250205005250_20250205005250:0/",
            "pub_date": "2025-02-05 20:30:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2025-02-05:newsml_GNX7NKwqP:0",
            "title": "HydroGraph Achieves ISO 9001:2015 Certification, Strengthening Commitment to Quality Management",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><span><p class=\"\">ISO 9001 certification highlights HydroGraph’s dedication to producing high-quality graphene with exceptional batch-to-batch consistency</p><p class=\"\">TORONTO, Feb.  05, 2025  (GLOBE NEWSWIRE) — HydroGraph Clean Power Inc.  (OTCQB: HGRAF) (FRA: M98) (the “Company” or “HydroGraph”), an industry-leading sustainable commercial manufacturer of pristine graphene, is proud to announce that it has achieved ISO 9001:2015 certification. This certification reaffirms HydroGraph’s commitment to consistently delivering one of the highest graphene products on the market.</p><p class=\"\">The ISO 9001 certification is one of the most recognized international standards for quality management. Earning this certification demonstrates that HydroGraph has established robust processes to <strong class=\"root-Tkn6WL2y\">i</strong>mplement, maintain, and continuously improve its quality management practices.</p><p class=\"\">“I am incredibly proud of our team for achieving this ISO 9001:2015 certification,” said Kjirstin Breure, CEO and President of HydroGraph. “This milestone is a testament to our unwavering dedication to quality and excellence. This certification is critical in the pursuit of large-scale commercial partnerships and aligns with the expectations of our target markets. I am excited to see how this achievement will further elevate HydroGraph and its products.”</p><p class=\"\">Beyond enhancing customer confidence, the ISO 9001:2015 certification positions HydroGraph for significant operational scale-up. It assures customers and stakeholders that HydroGraph adheres to top-tier quality standards while maintaining rigorous, data-driven processes.</p><p class=\"\">Key benefits of HydroGraph’s ISO 9001:2015 certification include:</p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><strong class=\"root-Tkn6WL2y\">Enhanced Customer Satisfaction:</strong> Ensures that HydroGraph consistently meets and exceeds customer satisfaction while fostering continuous improvement.</li><li class=\"listItem-bmN0_SHH\"><strong class=\"root-Tkn6WL2y\">Global Recognition &amp; Credibility: </strong>Reinforces HydroGraph’s reputation as a trusted global supplier, committed to internationally recognized quality standards.</li><li class=\"listItem-bmN0_SHH\"><strong class=\"root-Tkn6WL2y\">Risk Management:</strong> Implements a structured approach to proactively identify and mitigate risks, ensuring consistent product quality.</li><li class=\"listItem-bmN0_SHH\"><strong class=\"root-Tkn6WL2y\">Commitment to Continuous Improvement:</strong> Supports HydroGraph’s ongoing efforts to refine its processes, drive innovation, and sustain long-term growth.</li></ul><p class=\"\">“Our ISO 9001:2015 certification complements our existing Graphene Council verification,” added Breure. “The combination of both the ISO certification and the Council verification confirms the authenticity and precision of our graphene. Quality has always been at the core of our company, and we remain steadfast in our commitment to data-driven decision-making and risk management as we drive HydroGraph’s future growth.”</p><p class=\"\">For more information about HydroGraph, please visit www.hydrograph.com.</p><p class=\"\"><strong class=\"root-Tkn6WL2y\">ABOUT HYDROGRAPH CLEAN POWER INC.</strong> </p><p class=\"\">HydroGraph Clean Power Inc is a leading producer of pristine graphene using an “explosion synthesis” process, which allows for exceptional purity, low energy use and identical batches. The quality, performance and consistency of HydroGraph’s graphene follows the Graphene Council’s Verified Graphene Producer® standards, of which very few graphene producers are able to meet. For more information or to learn about the HydroGraph story, visit: https://hydrograph.com/. For company updates, please follow HydroGraph on LinkedIn and X. </p><p class=\"\"><strong class=\"root-Tkn6WL2y\">Forward-Looking Statements</strong> </p><p class=\"\">This release contains certain “forward looking statements” and certain “forward-looking information” as defined under applicable Canadian securities laws. Forward-looking statements and information can generally be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “intend”, “estimate”, “upon” “anticipate”, “believe”, “continue”, “plans” or similar terminology. </p><p class=\"\">Forward-looking statements and information include, but are not limited to: statements in respect of the Private Placement, the use of the net proceeds from the Private Placement, </p><p class=\"\">the timing and ability of the Company to close the Private Placement, if at all, the gross proceeds of the Private Placement, the timing and ability of the Company to obtain all necessary regulatory approvals, if at all, and the terms and jurisdictions of the Private Placement; the statements in regards to existing and future products of the Company; the Company’s future personnel appointments; the Company’s plans and strategies. </p><p class=\"\">Forward-looking statements and information are based on forecasts of future results, estimates of amounts not yet determinable and assumptions that, while believed by management to be reasonable, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Forward-looking statements and information are subject to various known and unknown risks and uncertainties, many of which are beyond the ability of HydroGraph to control or predict, that may cause HydroGraph’s actual results, performance or achievements to be materially different from those expressed or implied thereby, and are developed based on assumptions about such risks, uncertainties and other factors set out herein, including but not limited to: HydroGraph’s ability to implement its business strategies; risks associated with general economic conditions; adverse industry events; stakeholder engagement; marketing and transportation costs; loss of markets; volatility of commodity prices; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; industry and government regulation; changes in legislation, income tax and regulatory matters; competition; currency and interest rate fluctuations; and other risks. HydroGraph does not undertake any obligation to update forward-looking information except as required by applicable law. Such forward-looking information represents management’s best judgment based on information currently available. </p><p class=\"\">No forward-looking statement can be guaranteed, and actual future results may vary materially. Accordingly, readers are advised not to place undue reliance on forward-looking statements. </p><p class=\"\"><strong class=\"root-Tkn6WL2y\">CONTACTS</strong></p><p class=\"\"><strong class=\"root-Tkn6WL2y\">HydroGraph Investor Relations</strong></p><p class=\"\">Matt Kreps, Darrow Associates IR</p><p class=\"\">mkreps@darrowir.com</p><p class=\"\">Kjirstin Breure, HydroGraph President and CEO </p><p class=\"\">kjirstin.breure@hydrograph.com</p><p class=\"\">408.267.2556</p><p class=\"\"><strong class=\"root-Tkn6WL2y\">HydroGraph Media Contact</strong></p><p class=\"\">Raven Carpenter </p><p class=\"\">hydrograph@fox.agency</p><p class=\"\">646.665.1107</p></span></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2025-02-05:newsml_GNX7NKwqP:0-hydrograph-achieves-iso-9001-2015-certification-strengthening-commitment-to-quality-management/",
            "pub_date": "2025-02-05 20:30:00",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2025-02-05:newsml_GNX7FpjBD:0",
            "title": "Hydreight Technologies Expands Telehealth Offerings with Launch of NAD+ Therapy on VSDHOne Platform",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><span><p class=\"\">VANCOUVER, British Columbia and LAS VEGAS, Feb.  05, 2025  (GLOBE NEWSWIRE) — Hydreight Technologies Inc. (“Hydreight”or the “Company”)(TSXV: NURS)(OTCQB: HYDTF)(FSE: SO6), a fast-growing mobile clinical network and medical platform which enables flexible at-home medical services across 50 states in the United States, is pleased to announce the expansion of its VSDHOne platform with the launch of <strong class=\"root-Tkn6WL2y\">Nicotinamide Adenine Dinucleotide (NAD+) therapy</strong> in three new delivery formats: <strong class=\"root-Tkn6WL2y\">patch, injection, and nasal spray</strong>. This development further strengthens Hydreight’s commitment to providing innovative and accessible wellness solutions through its national telehealth network. This launch positions Hydreight to capitalize on the rapidly expanding anti-aging and longevity market.</p><p class=\"\"><strong class=\"root-Tkn6WL2y\">What is NAD+?</strong></p><p class=\"\">Nicotinamide Adenine Dinucleotide (<strong class=\"root-Tkn6WL2y\">NAD+</strong>) is a <strong class=\"root-Tkn6WL2y\">coenzyme essential for metabolism</strong>, found in all living cells. It plays a critical role in <!-- -->energy production, cellular repair, and DNA maintenance. As a coenzyme in redox reactions, NAD+ helps convert nutrients into energy, making it <!-- -->central to mitochondrial function and overall cellular health.</p><p class=\"\">NAD as an injectable has been around for awhile, but bringing it to patients homes and expanding for those who do not like giving themselves injections to the additional dosage forms allows VSDHOne to serve a broader population. The nasal spray is more immediate delivery as well and the into patch delivery is focused to carry the NAD to the area the patch is applied.</p><p class=\"\"><strong class=\"root-Tkn6WL2y\">The Growing Anti-Aging and Longevity Market</strong></p><p class=\"\">The global <strong class=\"root-Tkn6WL2y\">anti-aging market</strong> is experiencing significant growth, driven by increasing consumer demand for products and treatments that promote <strong class=\"root-Tkn6WL2y\">longevity and mitigate the effects of aging</strong>. In 2024, the market was valued at approximately <strong class=\"root-Tkn6WL2y\">$73 billion</strong> and is projected to reach around <strong class=\"root-Tkn6WL2y\">$140.94 billion by 2034</strong> (Precedence Research). This growth is attributed to advancements in biotechnology, rising consumer awareness about longevity solutions, and a growing aging population seeking to maintain optimal health. Hydreight’s expansion into NAD+ therapy aligns with this trend, positioning the company at the forefront of <strong class=\"root-Tkn6WL2y\">science-backed longevity treatments</strong>.</p><p class=\"\"><strong class=\"root-Tkn6WL2y\">Benefits of NAD+ Therapy</strong></p><p class=\"\">NAD+ supplementation is widely used for its potential <strong class=\"root-Tkn6WL2y\">anti-aging, cognitive, and metabolic benefits</strong>, including:</p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><strong class=\"root-Tkn6WL2y\">Improved cognitive function</strong> and neuroprotection.</li><li class=\"listItem-bmN0_SHH\"><strong class=\"root-Tkn6WL2y\">Enhanced energy levels</strong> and mitochondrial support.</li><li class=\"listItem-bmN0_SHH\"><strong class=\"root-Tkn6WL2y\">Potential weight management</strong> benefits.</li><li class=\"listItem-bmN0_SHH\"><strong class=\"root-Tkn6WL2y\">Reduction in pain and inflammation</strong>, promoting overall well-being.</li><li class=\"listItem-bmN0_SHH\"><strong class=\"root-Tkn6WL2y\">Support for ATP production</strong>, the body’s primary energy source.</li><li class=\"listItem-bmN0_SHH\"><strong class=\"root-Tkn6WL2y\">Improved athletic performance</strong> and reduced fatigue.</li><li class=\"listItem-bmN0_SHH\"><strong class=\"root-Tkn6WL2y\">Cholesterol management</strong>, mood regulation, and blood pressure control.</li><li class=\"listItem-bmN0_SHH\"><strong class=\"root-Tkn6WL2y\">Potential neuroprotective effects</strong> in managing neurodegenerative diseases.</li><li class=\"listItem-bmN0_SHH\"><strong class=\"root-Tkn6WL2y\">Liver detoxification</strong> and reversal of alcohol-induced oxidative stress.</li></ul><p class=\"\"><strong class=\"root-Tkn6WL2y\">Mechanism of Action</strong></p><p class=\"\">NAD+ functions as a coenzyme within <strong class=\"root-Tkn6WL2y\">oxidoreductases</strong>, playing a crucial role in numerous <strong class=\"root-Tkn6WL2y\">biochemical processes</strong> that impact overall health and longevity. By supporting <strong class=\"root-Tkn6WL2y\">energy metabolism and DNA repair</strong>, NAD+ therapy can provide a broad range of physiological benefits.</p><p class=\"\">NAD+ Therapy Now Available on VSDHOne in Three Delivery Formats</p><p class=\"\">Hydreight’s VSDHOne platform now offers <strong class=\"root-Tkn6WL2y\">three convenient administration routes</strong> for NAD+ therapy, providing flexibility for patients to choose the option that best fits their lifestyle:</p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><strong class=\"root-Tkn6WL2y\">NAD+ Injection</strong> (IM/SQ) – <!-- -->Self-administered intramuscular (IM) or subcutaneous (SQ) injection, allowing for <strong class=\"root-Tkn6WL2y\">direct absorption and rapid bioavailability</strong>.</li><li class=\"listItem-bmN0_SHH\"><strong class=\"root-Tkn6WL2y\">NAD+ Intranasal Spray</strong> – A <strong class=\"root-Tkn6WL2y\">daily-administered nasal spray</strong> offering a convenient and effective way to increase NAD+ levels.</li><li class=\"listItem-bmN0_SHH\"><strong class=\"root-Tkn6WL2y\">NAD+ IonToPatch</strong> – Utilizing <strong class=\"root-Tkn6WL2y\">iontophoresis</strong>, a non-invasive transdermal drug delivery system that uses a voltage gradient to increase skin permeability, allowing for effective NAD+ absorption. <strong class=\"root-Tkn6WL2y\">The latex-free patch</strong> features a 4-hour wear time and is designed for <strong class=\"root-Tkn6WL2y\">patients with active lifestyles</strong>, delivering <strong class=\"root-Tkn6WL2y\">80 mA/min with a 1mL fill volume</strong></li></ul><p class=\"\"><strong class=\"root-Tkn6WL2y\">Expanding Access to Innovative Wellness Solutions</strong></p><p class=\"\">The addition of <strong class=\"root-Tkn6WL2y\">NAD+ therapy</strong> to VSDHOne aligns with Hydreight’s vision of making <strong class=\"root-Tkn6WL2y\">advanced wellness treatments more accessible</strong> through its nationwide network of healthcare providers. The VSDHOne platform streamlines the <strong class=\"root-Tkn6WL2y\">prescription, consultation, and delivery process</strong>, ensuring that patients can receive <!-- -->high-quality, science-backed treatments conveniently and safely.</p><p class=\"\">The NAD+ therapy options will be available to all VSDHOne customers, ensuring widespread access to these innovative wellness treatments.</p><p class=\"\">“NAD+ therapy has gained significant attention for its role in cellular health and longevity,” said Shane Madden, CEO of Hydreight Technologies Inc. “By integrating NAD+ into our VSDHOne platform, we are making it easier for patients to access this powerful coenzyme in multiple convenient formats, ensuring they can benefit from its potential impact on energy, cognition, and overall wellness.”</p><p class=\"\">On behalf of the Board of Directors</p><p class=\"\">Shane Madden</p><p class=\"\">Director and Chief Executive Officer</p><p class=\"\">Hydreight Technologies Inc.</p><p class=\"\">Hydreight Technologies Inc Ranked Number 56 Fastest-Growing Company in North America on the <em>2024 Deloitte Technology Fast 500™</em></p><p class=\"\">Contact</p><p class=\"\">Email: ir@hydreight.com; Telephone: 1 (702) 970-8112</p><p class=\"\"><strong class=\"root-Tkn6WL2y\">About Hydreight Technologies Inc.</strong></p><p class=\"\">Hydreight Technologies Inc is building one of the largest mobile clinic network in the United States. Its proprietary, fully integrated platform hosts a network of over 2500 nurses, over 100 doctors and a pharmacy network across 50 states. The platform includes a built-in, easy-to-use suite of fully integrated tools for accounting, documentation, sales, inventory, booking, and managing patient data, which enables licensed healthcare professionals to provide services directly to patients at home, office or hotel. Hydreight is bridging the gap between provider compliance and patient convenience, empowering nurses, med spa technicians, and other licensed healthcare professionals. The Hydreight platform allows healthcare professionals to deliver services independently, on their own terms, or to add mobile services to existing location-based operations. Hydreight has a 503B pharmacy network servicing all 50 states and is closely affiliated with a U.S. certified e-script and telemedicine provider network.</p><p class=\"\">This press release does not constitute an offer of securities for sale in the United States. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and such securities may not be offered or sold within the United States absent U.S. registration or an applicable exemption from U.S. registration requirements.</p><p class=\"\"><strong class=\"root-Tkn6WL2y\">About VSDHOne - Direct to Consumer Platform</strong></p><p class=\"\">Developed in partnership with Victory Square Technologies   , Hydreight Technologies launched the VSDHOne (Read as VSDH-One) platform. VSDHOne simplifies the entry challenges for companies and medi-spa businesses to enter the online healthcare space compliantly. This platform will help all businesses to launch a direct-to-consumer healthcare brand in a matter of days in all 50 states. Compliant offerings include: GLP-1s (semaglutide, tirzepatide), peptides, personalized healthcare treatments, sermorelin, testosterone replacement therapy (“TRT”), hair loss, skincare, sexual health and more. Hydreight invested in technology, legal and infrastructure to launch this platform. The VSDHOne platform offers a complete, end-to-end solution for businesses looking to launch direct-to-consumer healthcare brands. From compliance and telemedicine technology to nationwide doctor and pharmacy networks, VSDHOne provides all the tools needed for a seamless entry into the online healthcare space. The platform is designed to significantly reduce the time and costs associated with launching such services, making it possible for businesses to go live in days instead of months.</p><p class=\"\">Neither TSXV nor its Regulation Services Provider (as that term is defined in policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release. This press release does not constitute an offer of securities for sale in the United States. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and such securities may not be offered or sold within the United States absent U.S. registration or an applicable exemption from U.S. registration requirements.</p><p class=\"\">Cautionary Note Regarding Forward-Looking Information</p><p class=\"\">This press release contains statements which constitute “forward-looking information” within the meaning of applicable securities laws, including statements regarding the plans, path to profitability, intentions, beliefs and current expectations of the Company with respect to future business activities and operating performance. Forward-looking information is often identified by the words “may”, “would”, “could”, “should”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “projecting”, “expect” or similar expressions and includes information regarding expectations for the Company's growth,</p><p class=\"\">Investors are cautioned that forward-looking information is not based on historical facts but instead reflects the Company’s management’s expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the Company. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: the ability to obtain requisite regulatory and other approvals with respect to the business operated by the Company and/or the potential impact of the listing of the Company’s shares on the TSXV on relationships, including with regulatory bodies, employees, suppliers, customers and competitors; changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; compliance with extensive government regulation; and the diversion of management time as a result of being a publicly listed entity. This forward-looking information may be affected by risks and uncertainties in the business of the Company and market conditions.</p><p class=\"\">Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.</p></span></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2025-02-05:newsml_GNX7FpjBD:0-hydreight-technologies-expands-telehealth-offerings-with-launch-of-nad-therapy-on-vsdhone-platform/",
            "pub_date": "2025-02-05 20:30:00",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20250205005228:0",
            "title": "Griffon Corporation Declares Quarterly Dividend",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><span><p class=\"\">Griffon Corporation Declares Quarterly Dividend</p><p class=\"\">NEW YORK--(BUSINESS WIRE)--February 05, 2025--</p><p class=\"\">The Board of Directors of Griffon Corporation  (the \"Company\" or \"Griffon\") yesterday declared a regular quarterly cash dividend of $0.18 per share. The dividend is payable on March 18, 2025 to shareholders of record as of the close of business on February 25, 2025.</p><p class=\"\">About Griffon Corporation</p><p class=\"\">Griffon is a diversified management and holding company that conducts business through wholly-owned subsidiaries. Griffon oversees the operations of its subsidiaries, allocates resources among them and manages their capital structures. Griffon provides direction and assistance to its subsidiaries in connection with acquisition and growth opportunities as well as divestitures. As long-term investors, we intend to continue to grow and strengthen our existing businesses, and to diversify further through investments in our businesses and acquisitions.</p><p class=\"\">Griffon conducts its operations through two reportable segments:</p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\">Home and Building Products conducts its operations through Clopay   Corporation (\"Clopay\"). Founded in 1964, Clopay is the largest   manufacturer and marketer of garage doors and rolling steel doors in   North America. Residential and commercial sectional garage doors are sold   through professional dealers and leading home center retail chains   throughout North America under the brands Clopay, Ideal, and Holmes.   Rolling steel door and grille products designed for commercial,   industrial, institutional, and retail use are sold under the Cornell and   Cookson brands.     </li><li class=\"listItem-bmN0_SHH\">Consumer and Professional Products (\"CPP\") is a global provider of   branded consumer and professional tools; residential, industrial and   commercial fans; home storage and organization products; and products   that enhance indoor and outdoor lifestyles. CPP sells products globally   through a portfolio of leading brands including AMES, since 1774, Hunter,   since 1886, True Temper, and ClosetMaid.   </li></ul><p class=\"\">For more information on Griffon and its operating subsidiaries, please see the Company's website at www.griffon.com.</p><p class=\"\">View source version on businesswire.com: https://www.businesswire.com/news/home/20250204592037/en/</p><p class=\"\">CONTACT:    Company Contact:</p><p class=\"\">Brian G. Harris</p><p class=\"\">EVP &amp; Chief Financial Officer</p><p class=\"\">Griffon Corporation</p><p class=\"\">(212) 957-5000</p><p class=\"\">IR@griffon.com</p><p class=\"\">Investor Relations Contact:</p><p class=\"\">Tom Cook</p><p class=\"\">Managing Director</p><p class=\"\">ICR Inc.</p><p class=\"\">(203) 682-8250</p></span></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20250205005228:0/",
            "pub_date": "2025-02-05 20:30:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        }
    ]
}